---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-142304"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-26T00:01:17.540767+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Definitive Healthcare Q1 revenue $50.1M (+36% YoY); CEO transition to Musslewhite in August

## Summary
- Revenue $50.1M, +36% YoY; net loss ($13.1M) widened from ($10.5M); adjusted net income $7.7M (vs $2.6M).
- Adjusted EBITDA $14.0M (28% of revenue) vs $14.1M (38%) in Q1 2021; cash from ops $13.6M.
- Q2 2022 guidance: revenue $53-54M (+34%); full year revenue $220.5-224.5M (+33-35%).
- Robert Musslewhite (President) appointed CEO effective Aug 1, 2022; founder Jason Krantz becomes Executive Chairman.
- Musslewhite receives annual base salary $429k, RSU grants, and change-in-control benefits; Krantz retains reduced salary and equity.

## SEC filing metadata
- accession: 0001193125-22-142304
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/d329213d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-142304
- JSON: https://secwatch.observer/filing/0001193125-22-142304.json
- Plain text: https://secwatch.observer/filing/0001193125-22-142304.txt

## Key facts
- Executive change
  Robert Musslewhite was appointed as Chief Executive Officer at Definitive Healthcare Corp..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On May 5, 2022, the Company announced that on May 3, 2022 its Board of Directors (the “Board”) appointed Robert Musslewhite, the Company’s current President, to the position of Chief Executive Officer (“CEO”), effective August 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm
- Executive change
  Jason Krantz changed role as Executive Chairman at Definitive Healthcare Corp..
  - Action: stepped down as CEO and became
  - Role: Executive Chairman
  source text: Effective on August 1, 2022, Jason Krantz, the Company’s founder, Chairman of the Board and current CEO will step down from his role as CEO, and become Executive Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.